In the US, Oxcarbazepine (oxcarbazepine systemic) is a member of the drug class dibenzazepine anticonvulsants and is used to treat Anxiety, Bipolar Disorder, Seizures and Trigeminal Neuralgia.
US matches:
- Oxcarbazepine
- Oxcarbazepine Suspension
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N03AF02
CAS registry number (Chemical Abstracts Service)
0028721-07-5
Chemical Formula
C15-H12-N2-O2
Molecular Weight
252
Therapeutic Category
Antiepileptic agent
Chemical Name
10,11-Dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide
Foreign Names
- Oxcarbazepinum (Latin)
- Oxcarbazepin (German)
- Oxcarbazépine (French)
- Oxcarbazepina (Spanish)
Generic Names
- Oxcarbazepine (OS: BAN, USAN)
- Oxcarbazépine (OS: DCF)
- GP 47680 (IS: Geigy)
- KIN-493 (IS)
Brand Names
- Actinum
Armstrong, Mexico - Apydan
Algol, Finland; Desitin, Germany; Desitin, Denmark; Desitin, Estonia; Desitin, Hungary; Desitin, Poland - Auram
Aché, Brazil - Aurene
Ivax, Argentina - Barzepin
Novell, Indonesia - Deprectal
Psicofarma, Mexico - Deprectal-S
Psicofarma, Mexico - Epilexter
Laboratorios Dr Esteve, Spain - Karbox
Merck, Slovenia - Leptal
Healthcare, Bangladesh - Lonazet
Legrand, Colombia - Neurtrol
Genovate, Taiwan - Oxca
Bouzen, Argentina - Oxcarbacepin CT
CT Arzneimittel, Germany - Oxcarbacepin-ratiopharm
Ratiopharm, Germany - Oxcarbatol
Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Oman; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Yemen - Oxcarbazepin Arcana
Arcana, Austria - Oxcarbazepin dura
Mylan dura, Germany - Oxcarbazepin Merck NM
Merck NM, Denmark - Oxcarbazepin Mylan
Mylan, Sweden - Oxcarbazepina Merck
Merck Genericos, Spain - Oxcarbazepina Mylan
Mylan, Italy - Oxcarbazepin-CT
CT Arzneimittel, Germany - Oxcarbazepine Generics
Generics, Greece - Oxcarbazepine Mylan
Mylan, Belgium - Oxcarbazépine Mylan
Mylan, France - Oxcarbazépine Teva
Teva Santé, France - Oxcarbazepine
Apotex, United States; Breckenridge, United States; Cadista, United States; Glenmark, United States; Ranbaxy, United States; Roxane, United States; Sun, United States; Taro, United States; Teva USA, United States - Oxetol
Sun, Myanmar; Sun Pharma, Mexico - Oxicodal
Drugtech-Recalcine, Chile - Oxilepsi
Eczacibasi, Turkey - Oxrate
Merind, India - Prolepsi
Mersifarma, Indonesia - Rupox
Medipharma, Argentina - Tevaleptin
Ivax, Bulgaria; Pharmachemie, Bulgaria; Teva, Bulgaria; Teva, Bulgaria - Timox
Desitin, Germany - Tolep
Novartis, Italy - Trileptal
1A Pharma, Germany; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Bangladesh; Novartis, Belgium; Novartis, Bulgaria; Novartis, Bulgaria; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Iceland; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam; Novartis, South Africa; Novartis Pharmaceuticals, Peru - Trileptin
Novartis, Israel
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment